basic FGF (bFGF), which is a mitogen for more differentiResults ated oligodendrocytes (Eccleston and Silberberg, 1984;  GGF Is a Potent Mitogen with Pleiotropic Effects Fressinaud et al., 1995; Saneto and Vellis, 1985) . When on Cells of the Oligodendrocyte Lineage used in combination, these two growth factors cooperTo investigate the potential effects of GGF on cells of the ate to inhibit the differentiation and maintain the proliferoligodendrocyte lineage, we first established cultures of ation of oligodendrocyte progenitors (Bö gler et al., 1990;  oligodendrocyte progenitors from neonatal rat cortex Collarini et al., 1992; McKinnon et al., 1990) . PDGF and, essentially as described (Louis et al., 1992) . Cells were possibly, bFGF also promote the survival of oligodenexpanded by supplementing the media with B104 condidrocyte progenitors (Barres et al., 1992; Yasuda et al., tioned media. Cells in the supplemented media had a 1995). Other factors that promote proliferation or surbipolar morphology and remained highly proliferative, vival (or both) of oligodendrocyte progenitors include and >95% of the cells expressed vimentin and A2B5, neurotrophin-3 and insulin-like but not O4, O1, or GFAP. When switched to a defined growth factor (McMorris and Dubois-Dalcq, 1988 ; for a media to which 0.5% serum was added to enhance review, see Barres and Raff, 1994) . All of these factors survival (DM ϩ ), the cells rapidly acquired a multipolar are released by astrocytes; bFGF and PDGF are exmorphology and began to express the O4 antigen. After pressed and released by neurons as well (Dutly and several days, the cells developed a complex network of Schwab, 1991; Hardy and Reynolds, 1993a; Pettman et processes and began to express the O1 antigen. By 3 al., 1986; Yeh et al., 1991) . days in DM ϩ , essentially all cells were O4ϩ and over 50% Neurons and a neuronal cell line also release a mitowere O1ϩ and MBPϩ. Cell differentiation coincided with gen(s) that is distinct from either PDGF or bFGF (Gard a substantial reduction in the proliferative rate. The laand Pfeiffer, 1990; Hardy and Reynolds, 1993b; beling index of cells grown in B104 conditioned media and Bottenstein, 1991; Levine, 1989) . We considered was greater than 50% after a 4 hr pulse of bromodeoxywhether the neuregulins might correspond to this unuridine (BrDU) but decreased to less than 5% when cells identified mitogenic activity. The neuregulins are a family were grown in DM ϩ for 3 days. of soluble and transmembrane protein isoforms enTo characterize the effects of GGF, cells grown in DM ϩ coded by a single gene that includes the glial growth for 3 days were treated with 200 ng/ml GGF for 16 hr, factors (GGFs), the neu differentiation factor (NDF), the the last 4 hr in the presence of BrDU. Cells were then heregulins, and the acetylcholine receptor-inducing acfixed and stained for O4, O1, and BrDU. The results, tivity (ARIA) (Marchionni et al., 1993; Peles and Yarden, shown in Figure 1 , demonstrate that GGF had a number 1993). These proteins mediate their effects by binding of dramatic effects. After GGF treatment, all cells reto and signaling via a family of receptor tyrosine kinases mained O4ϩ ( Figure 1B ), but most treated cells had a comprised of erbB2, erbB3, and erbB4 (reviewed by less complex morphology than control cells ( Figure 1A ), Carraway and Burden, 1995) . Although initially purified with fewer and flatter processes suggestive of a less as a potential ligand for erbB2, recent studies suggest mature phenotype. Consistent with this change in morthat neuregulins bind to erbB3 and erbB4, which heterophology, significantly fewer O1ϩ cells were present after dimerize in various combinations with each other, and GGF treatment compared with controls (Figures 1C and with erbB2 and the epidermal growth factor receptor to 1D). Finally, there was a substantial increase in the numeffect subsequent signaling.
ber of BrDU-positive nuclei in the treated compared with We now report that a soluble recombinant form of the control cells (Figures 1E and 1F) . We have quantihuman neuregulin, corresponding to glial growth factor tated these effects over a range of GGF concentrations. 2 (GGF2), is a potent mitogen for oligodendrocytes and
The labeling index was determined separately for O4ϩ their progenitors. GGF also blocks their differentiation and O1ϩ cells. In each case, the labeling index inat the O4ϩ stage and enhances the survival of these creased with higher concentrations of GGF ( Figure 1G ). cells. In addition, we demonstrate that the mitogenic This was paralleled by the loss in O1 expression (Figure effect of cortical neuron-conditioned media (CCM) on 1H). We consider first the mitogenic response to the oligodendrocyte progenitors is inhibited by antibodies neuregulins. to GGF. Finally, neuregulin receptors are shown to be GGF is a potent mitogen for O4ϩ cells. The labeling expressed in cells at various stages of the lineage and index of the O4ϩ cells increased significantly with concan be activated by exposure to GGF. These results centrations of GGF as low as 0.2 ng/ml and reached a indicate that the neuregulins are physiologic mitogens plateau of ‫%04ف‬ at concentrations of 200 ng/ml or for oligodendrocyte progenitors and have potent effects greater ( Figure 1G ); a half maximal response was observed with concentrations of GGF of about 20 ng/ml on their survival and differentiation. ‫5.0ف(‬ nM). The mitogenic effect is not specific for the observed that 3 days later, over 50% of the cells expressed high levels of GFAP and developed a stellate GGF isoform, as heregulin ␤1, another neuregulin isoform expressed in the CNS, also has proliferative effects. morphology characteristic of type-2 astrocytes ( Figure  3A ). In parallel, the labeling index rapidly declined to O4ϩ cells treated for 16 hr with conditioned media, with or without heregulin ␤1 (Jo et al., 1995) , displayed a 2.5% Ϯ 0.7% ( Figure 3C ). After treatment with GGF for 16 hr, there was a striking change in the morphology of comparably robust mitogenic response. Thus, cultures treated with control media had a labeling index of the astrocytes with some cells exhibiting a few highly extended GFAPϩ processes ( Figure 3B ). Of particular 3.4% Ϯ 0.4%, whereas heregulin ␤1-treated cultures had a labeling index of 33.3% Ϯ 2.4%.
note, the labeling index of the total population of cells increased markedly to 14.5% Ϯ 1.2% ( Figure 3D ). Most GGF is also mitogenic for O1ϩ cells, although they appear to be less responsive than the total population of the BrDUϩ cells were GFAPϪ. In separate experiments, type-2 astrocytes, identified by double labeling of O4ϩ cells. The labeling index of O1ϩ cells in the control cultures was 0%; it increased to nearly 5% with with GFAP, also demonstrated a modest but significant mitogenic response, with the labeling index increasing concentrations of GGF up to 20 ng/ml and increased to just above 15% at higher concentrations of GGF (200-from 0% in the controls to 8% in the GGF-treated cultures. 2000 ng/ml). In separate experiments, a similar mitogenic effect on MBPϩ cells was also observed, i.e., there were no MBPϩ/BrDUϩ cells in controls versus
GGF Has Direct Mitogenic Effects
We next examined whether the mitogenic activity of 16.7% Ϯ 4.3% in the cultures treated with 200 ng/ml GGF. A representative example of an MBPϩ cell that GGF was direct or whether GGF stimulated proliferation by inducing progenitor cells to release another growth incorporated BrDU is shown in Figure 2 . However, because GGF treatment may down-regulate the expresfactor that in turn increased proliferation. To this end, we first determined the neutralizing activity of an antision of these mature markers as described below, these studies may underestimate the actual mitogenic rebody to GGF. Preincubating GGF with this antibody prior to adding it to O4ϩ cells completely inhibited its mitosponse of oligodendrocytes.
Indeed, one of the most striking effects of short-term genic effect ( Figure 4A) ; the same antibody did not inhibit the mitogenic effect of bFGF or PDGF, thereby demontreatment with GGF was a marked decrease in the number, and percentage, of O1ϩ cells from these more difstrating its specificity (data not shown). We next collected media conditioned by O4ϩ cells grown for 1 day ferentiated cultures. This decrease was dose dependent and inversely correlated with the mitogenic response to with GGF (200 ng/ml) and added this media to cells directly or after preincubation with the GGF neutralizing GGF (see Figures 1G and 1H ). Treatment with 200 ng/ ml GGF resulted in a dramatic reduction in the absolute antibody. Conditioned media from GGF-treated cells, when added directly, resulted in a 6-fold increase in the number of 04ϩ/01ϩ cells from 26.5 Ϯ 4.8 per high power field (HPF) in control cultures to 4.5 Ϯ 0.7 per HPF; thus, labeling index of the recipient O4ϩ cells after 16 hr ( Figure 4B ). The mitogenic effect of this conditioned the percentage decrease in 04ϩ/01ϩ cells is not due to a selective expansion of 04ϩ/01Ϫ cells by GGF. In media was completely inhibited by preincubation with the anti-GGF antibody. Incubation with an anti-PDGF separate experiments, a similar decrease in the absolute number of MBPϩ cells was observed in GGF and hereantibody, which was used as an antibody control, had no effect on the mitogenic activity of the conditioned gulin ␤1-treated cultures. These findings suggest that the loss of O1 and MBP expression reflects reversion media. These results demonstrate that the mitogenic effect of GGF on O4ϩ cells is direct and does not result of O1ϩ cells to the O1Ϫ stage or selective cytotoxicity of neuregulins for O1ϩ cells (for example, see Muir and from the release of other mitogens into the conditioned media. . As total cell numbers increase during the period of GGF treatment and cells appear viable,
To determine whether the mitogenic activity of GGF was dependent on serum factors, oligodendrocyte prowe favor the former possibility. Further studies are underway to elucidate the precise mechanism involved. genitors were switched from media supplemented with B104 conditioned media to a defined media without any Finally, to determine whether GGF was mitogenic for type-2 astrocytes, O-2A cells growing in media suppleserum added. After 3 days, GGF was added to these cultures and the extent of proliferation was measured mented with B104 conditioned media were switched to media containing 20% fetal bovine serum (FBS). We as above. In the absence of serum and GGF, the rate of proliferation was markedly reduced, with a labeling or low concentrations of serum (for example, see Barres et al., 1992) . Consistent with earlier reports, we noted index of 0.4% Ϯ 0.2% after a 4 hr incubation with BrDU. In contrast, in cultures treated with 200 ng/ml GGF, the in the studies described above large numbers of dead cells in the control cultures following serum withdrawal. rate of proliferation was significantly increased, with a labeling index of 7.1% Ϯ 0.3%. These results indicate By contrast, GGF-treated cultures had notably fewer dead cells, strongly suggesting that GGF promotes the that the mitogenic effect of GGF on oligodendrocyte progenitors does not require serum, although it is greatly survival of oligodendrocyte progenitors. To directly examine whether GGF has survival effects for oligodendroenhanced in the presence of low concentrations of serum.
cyte progenitors, cells were grown in DM ϩ for 3 days then switched to a serum-free defined media with or without GGF. Survival was analyzed after an additional GGF Promotes Oligodendrocyte Progenitor Survival 12 or 24 hr. Initial experiments were done in N2 media and demonstrated that GGF strongly promoted oligoSurvival of oligodendrocyte progenitors in vitro is dependent on the presence of a number of growth factors dendrocyte progenitor survival as assessed by nuclear dye exclusion (data not shown). However, because the N2 media contains concentrations of insulin (5 g/ml) that enhance oligodendrocyte survival (Barres et al., 1992) , these experiments were repeated in Dulbecco's modified Eagle's medium (DMEM) without any supplements. Similar effects on survival were apparent under these more stringent conditions ( Figure 5 ). Thus, in the absence of GGF, ‫%05ف‬ of the cells were dead at 12 hr ( Figure 5A ), whereas at 200 ng/ml GGF only about 10% of the cells were dead. After 24 hr in DMEM, most of the cells were dead in the control cultures, whereas substantial numbers of viable cells remained in the treated cultures (data not shown). Consistent with this assay, the control wells had many more pyknotic cells in small aggregates than the GGF-treated wells; signifi- of GGF on O4ϩ cells were dose dependent with a half hr in DM ϩ without GGF (control), with GGF, with GGF and an antimaximal response of ‫2ف‬ ng/ml ( Figure 5C ).
PDGF antibody, or with GGF and an anti-GGF antibody; BrDU was added during the last 4 hr. Cells were fixed and the percentage of
Because of greatly improved cell survival in the pres- found that the mitogenic effects of GGF are sustained;
were O1ϩ or had acquired the complex morphology characteristic of mature oligodendrocytes (Figures 6C after 3 days of GGF treatment (200 ng/ml), the labeling index was greater than 30% (Table 1 ) and remained and 6D). This inhibition of differentiation reversed following withdrawal of GGF; we observed that 3 days after comparably elevated for several weeks provided that cells continued to be passaged in the presence of GGF GGF withdrawal, over 50% of the cells became 01ϩ. Thus, treatment with high doses of GGF reversibly (data not shown). Cells treated for 3 days with GGF were also analyzed for their expression of oligodendrocyte blocks oligodendrocyte differentiation at the O4ϩ/O1Ϫ stage. markers. Such cells progressed to the O4ϩ/O1Ϫ stage but were inhibited from differentiating to the O4ϩ/O1ϩ
GGF similarly inhibits differentiation of O-2A cells into type-2 astrocytes (Table 2) . Cells were switched to mestage (Table 1) . For example, after 3 days of GGF, essentially all cells were O4ϩ and had a multipolar morphology dia containing 20% FBS with or without 200 ng/ml GGF for 3 days. When grown in 20% FBS with GGF, fewer ( Figures 6A and 6B ), but less than 10% of the cells cells expressed detectable levels of GFAP than controls.
than 25% of the cells were induced to differentiate into O1ϩ oligodendrocytes (Table 2) . Taken together with Cells that did express GFAP had a unique morphology, characterized by a few highly extended, GFAPϩ prothe studies described above, these results indicate that GGF inhibits the differentiation of O-2A cells and maincesses ( Figures 6E and 6F ϩ with or without GGF (200 ng/ml) for 3 days, for 16 hr; BrDU was added for the last 4 hr. Analysis of BrDU incorporation showed that the CCM was mitoswitched all cells to media supplemented with 20% FBS without GGF for an additional 3 days, and then stained genic for cells in both conditions, inducing a 2-3-fold increase in cell proliferation in each case (see Figure 7) . for GFAP expression. Cells grown in DM ϩ without GGF had largely become committed to the oligodendrocyte lineage; despite switching to high serum conditions, less in 20% FBS with GGF and then switched to DM ϩ , more a maximal mitogenic response based on comparative dose response curves (data not shown). As shown in Figure 7A , cells switched to DM ϩ for 12 hr (which consisted of recently differentiated O4ϩ/O1Ϫ cells) displayed a robust response to all three growth factors. In contrast, more mature cells that had been maintained in DM ϩ for 3 days had significantly different mitogenic response to these growth factors. In particular, the mitogenic effect of PDGF was markedly diminished on these more differentiated cells, whereas that of bFGF was increased in general agreement with previous reports (for example, see Gard and Pfeiffer, 1993) . The mitogenic effect of GGF was similar for cells in both cases, indicating that it has a pattern of mitogenic activity distinct from either bFGF or PDGF.
To identify which, if any, of these polypeptide growth factors were released by cerebral neurons, we incubated the CCM with various neutralizing antibodies for 30 min prior to adding it to cells maintained in DM ϩ for either 12 hr or 3 days. Results are shown in Figure 7B . In both cases, the anti-GGF antibody significantly inhibited the CCM-induced proliferation. The inhibition of proliferation was more pronounced with the mature O4ϩ cultures (3 days in DM ϩ ) as compared with the newly differentiated O4ϩ cells, i.e, a 68% inhibition of the CCM effect compared with a 48% inhibition, respectively. We also observed a significant inhibition of proliferation with the anti-PDGF antibodies, particularly in the case of the newly differentiated O4ϩ cells (12 hr in DM ϩ ). By contrast, there were no significant effects of the antibFGF antibodies on the mitogenic activity of the CCM when it was tested on cells grown for 3 days in DM ϩ . tioned media, from type-2 astrocyte-enriched cultures grown in 20% FBS, and from cells that increasingly differentiated into O4ϩ/O1ϩ oligodendrocytes grown in Immunofluorescence analysis revealed that essentially all of the cells had advanced to the O4ϩ stage at both DM ϩ for 1, 2, 3, or 4 days. Lysates were fractionated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) time points; therefore, the CCM was mitogenic for O4ϩ cells under the conditions tested. Double staining further and immunoblotted with a panel of receptor-specific antibodies. As controls, we analyzed lysates prepared demonstrated that all of the BrDU-positive cells were O4ϩ/O1Ϫ (data not shown). The CCM-treated cells had from rat Schwann cells and from newborn rat cerebrum. Results, shown in Figure 8A , demonstrate that, with the a distinctive multipolar morphology with four to ten wide flat processes consistent with our previous report exception of Schwann cells, which are known to express only erbB2 and erbB3 proteins (Levi et al., 1995) , all (Hardy and Reynolds, 1993b) and similar to the effects we observed with GGF treatment (see Figure 1) . three receptors were expressed in each cell type and in the brain. Of note, erbB3 is a prominent neuregulin We next compared the mitogenic response of the oligodendrocyte progenitors grown in DM ϩ for 12 hr or receptor protein in Schwann cells and in cells of the oligodendrocyte lineage. In contrast, erbB4 appears to for 3 days with a series of growth factors including bFGF (10 ng/ml), PDGF (10 ng/ml), and GGF (200 ng/ml). The predominate in the neonatal brain, which may reflect its high level expression by neurons in several regions of doses of growth factors used were chosen to provide the developing forebrain (characterized as tyro 2 in Lai and Lemke, 1991) . Of particular interest, as cells progress along the oligodendrocyte lineage, there is a decrease in erbB4 and an increase in erbB2 expression; in some experiments, this transition was even more pronounced than is shown here. Because these cultures, even those maintained in DM ϩ for 4 days, contain a mixture of O1Ϫ and O1ϩ cells, the expression of erbB4 may be even further reduced in the O1ϩ cells. Additional studies to address this point are in progress.
We next analyzed which proteins were phosphorylated following GGF treatment. GGF was briefly added to cultures of Schwann cells, to O-2As (in B104 conditioned media), to O4ϩ cells (3 days in DM ϩ ), and to type-2 astrocyte-enriched cultures (3 days in 20% FBS). Lysates were prepared, fractionated by SDS-PAGE, blotted, and probed with an anti-phosphotyrosine antibody. In each case, GGF treatment resulted in increased phosphorylation of a protein band of ‫581ف‬ kDa, with the O4ϩ cells demonstrating the most robust response ( Figure  8B ). In some experiments, a protein of similar size is constitutively phosphorylated at lower levels in the O-2A and O4ϩ cells. To determine which of the erbB receptors were phosphorylated following GGF treatment, tyrosine phosphorylated proteins were immunoprecipitated and analyzed by immunoblotting with antibodies specific for each of the receptor proteins ( Figure 8C ). As a control, total lysate from the O-2A cells was also analyzed. In each case, phosphorylated erbB3 is quite prominent. Phosphorylated forms of erbB2 and erbB4 were only readily detected in the case of the O4ϩ cells but were also present in the case of the type-2 astrocytes with higher sample loading (data not shown).
Discussion
GGF has long been known to be a potent mitogen for Schwann cells and astrocytes (Brockes et al., 1980) but had not been recognized previously to be a mitogen for oligodendrocytes. We have demonstrated in this report that GGF is also a potent mitogen and survival factor for cells of the oligodendrocyte lineage and inhibits the differentiation of pro-oligodendrocytes. These findings, and their implications for the neuronal regulation of oligodendrocyte development, are considered below.
GGF Is Released by Neurons and Is Mitogenic for Cells at Different Stages of the Oligodendrocyte Lineage
We have found that GGF has potent mitogenic effects B104 conditioned media, O4ϩ cells grown in DM ϩ for 3 days, and growing in B104 conditioned media, O4ϩ cells grown in DM ϩ for 3 type-2 astrocyte-enriched cultures grown in 20% FBS for 3 days days, and type-2 astrocyte-enriched cultures growing in 20% FBS were treated with GGF for 2.5 min and tyrosine phosphorylated for 3 days were lysed directly in detergent (Ϫ lanes) or after treatment proteins were immunoprecipitated, separated by SDS-PAGE, blotwith GGF for 2.5 min (ϩlanes). Detergent lysates (15 g/lane) were ted, and probed with erbB receptor-specific antibodies. A detergent subjected to SDS-PAGE, transferred onto nitrocellulose, and immulysate from untreated O-2A cells was run in the first lane as a control noblotted with an anti-phosphotyrosine antibody.
for antibody reactivity.
extent of receptor phosphorylation. This mitogenic ac-1989) and the neuroblastoma line B104 (Hunter and Bottenstein, 1991 ) also release a soluble mitogen(s) for olitivity operates directly and does not require serum cofactors, although it is significantly potentiated by low godendroglia that is distinct from PDGF and bFGF. We have found that neurons cultured from embryonic cereconcentrations of serum. We have not examined the mitogenic effect of GGF on undifferentiated O-2A cells, bral cortex release GGF into the culture media and that this GGF is mitogenic for pro-oligodendrocytes. With because, in the culture model we have used, these cells exhibit high basal levels of proliferation as a result of this report, GGF, heregulin ␤1, and potentially other neuregulin isoforms expressed in the CNS (Ho et al., 1995) expansion in the neuroblastoma conditioned media. However, addition of GGF results in the rapid tyrosine must now be considered likely neuronal mitogens for oligodendroglia. (In preliminary studies, we have also phosphorylation of a protein band of ‫581ف‬ kDa for O-2A cells, suggesting that GGF may also be mitogenic for detected secretion of GGF by the B104 neuroblastoma line.) In agreement with this possibility, cortical neurons, these cells. This has been confirmed in preliminary studies in which 5 ng/ml GGF resulted in a several fold inwhich would be expected to regulate the development of forebrain-derived oligodendrocyte progenitors, express crease in the proliferation of freshly panned GD3ϩ/O4Ϫ cells (R. R., unpublished data).
high levels of GGF during development (Chen et al., 1994) . GGF and other neuregulins may also function Previous studies have shown that regulation of oligodendrocyte proliferation is under the control of several as an axolemma-associated mitogen, as they do for Schwann cells (Rosenbaum et al., 1996 ; J. L. S., unpubmitogens that operate at different stages of the oligodendrocyte lineage. Thus, PDGF acts on early progenitors, lished data). Of interest in this regard, Nordlund et al. described the partial purification of a protein of 50 kDa whereas during the O4ϩ pro-oligodendrocyte stage, cells lose their responsiveness to PDGF and become from brain membrane preparations that is mitogenic for both Schwann cells and oligodendrocytes (Nordlund et increasingly responsive to bFGF (Gard and Pfeiffer, 1990) . The transition from O4ϩ/O1Ϫ progenitors to O1ϩ al., 1992) and have recently obtained evidence that it may correspond to GGF (Rosenbaum et al., 1996) . Taken oligodendrocytes coincides with a decrease in the mitogenic response to bFGF (Gard and Pfeiffer, 1993) . Our together, these results suggest that both soluble and membrane-associated forms of the neuregulins are results are consistent with these reports, as cells at an early stage of differentiation (12 hr in DM ϩ ) responded likely to play an important role in regulating oligodendrocyte progenitor proliferation during development. equally to PDGF and bFGF whereas cells at later stages of differentiation (3 days in DM ϩ ) were much more reBased on in situ hybridization, neurons and cells of the SVZ appear to be major sources of neuregulins in sponsive to bFGF than to PDGF. The proliferative effects of GGF are distinct from those of PDGF and bFGF in the developing and adult CNS (Corfas et al., 1995; OrrUrtreger et al., 1993; Vartanian et al., 1994) . In addition, that it is equally effective on newly differentiated O4ϩ cells and more mature O4ϩ cells. Indeed, GGF was astrocytes also synthesize these proteins (Pinkas- Kramarski et al., 1994) . While the identity of the cells exeven mitogenic for oligodendrocytes. The notion that the oligodendrocyte lineage is under the control of different pressing GGF in the SVZ has not yet been established, this region is primarily comprised of glial progenitors in mitogens is also in general agreement with the temporal pattern of expression of these growth factors in vivo.
the early postnatal period (Levison and Goldman, 1993) . These findings suggest that both neurons and glia may Both PDGF (Yeh et al., 1991) and the neuregulins (Corfas et al., 1995; Meyer and Birchmeier, 1994 ; Orr-Urtreger be physiologic sources of neuregulins during development. et al., 1993) are expressed very early during CNS development. The neuregulins, in particular, are expressed well before the oligodendrocyte progenitors are thought GGF Inhibits Lineage Commitment and to arise at approximately E16 in the rat forebrain (Levine Oligodendrocyte and Astrocyte Differentiation and Goldman, 1988) and they persist, at lower levels, Although axons are required for oligodendrocyte differinto adulthood. By contrast, bFGF mRNA expression in entiation and myelination, tissue culture studies suggest the brain is first detectable postnatally and increases that initially they promote proliferation and delay myeinto adulthood (Riva and Mocchetti, 1991) . Taken tolination of oligodendrocyte progenitors (Dutly and gether, these results suggest that GGF and PDGF are Schwab, 1991; Levine, 1989; Shaw et al., 1996 ; Zajicek likely to regulate early progenitors, including O-2As and and Compston, 1994) . This inhibition of differentiation early pro-oligodendrocytes, whereas GGF and bFGF results from axolemma-associated factors (Zajicek and may function at later times on more differentiated proCompston, 1994). After this initial delay, and once an oligodendrocytes and oligodendrocytes. Whether GGF appropriate cohort of oligodendrocytes is generated, a cooperates with these other growth factors to regulate later phase of differentiation ensues (Barres and Raff, the mitogenic response is an important question for 1994; Shaw et al., 1996; Wood and Bunge, 1991) . In future investigation. agreement with these initial effects of the axon, GGF Neurons are an important source of oligodendroglial promotes proliferation and significantly inhibits differenmitogens (Barres and Raff, 1994) , releasing soluble factiation of oligodendrocyte progenitors beyond the O4ϩ/ tors including PDGF (Dutly and Schwab, 1991; Zajicek O1Ϫ stage. These effects of GGF resemble those of and Compston, 1994) and bFGF (Hardy and Reynolds, bFGF, which, as noted above, arrests cells in the O4ϩ/ 1993b; Logan and Logan, 1986 ) and stimulating prolifer-O1Ϫ stage of differentiation (McKinnon et al., 1990 ). ation via contact-dependent factors (Chen and DeVries, Similar effects of mitogens on Schwann cell myelination 1989; Wood and Bunge, 1986) . Central neurons (Gard and Pfeiffer, 1990 ; Hardy and Reynolds, 1993b; Levine, (Einheber et al., 1995; Gué nard et al., 1995; Morgan et al., 1994), including GGF (Cheng and Mudge, 1996; J. L. S., here, we investigated whether the effects of GGF were isoform specific. We analyzed the mitogenic effects of unpublished data) have also been observed. These results indicate that high level expression of neuronal miheregulin ␤1, the human homolog of ARIA, and found it to be a potent mitogen, comparable in its efficacy with togens can promote proliferation and arrest myelination in both the CNS and PNS.
GGF. In addition, treatment with heregulin ␤1 also appears to result in a similar loss of MBPϩ cells in the The ability of GGF to inhibit oligodendrocyte differentiation raises the question of how oligodendrocytes differtreated cultures, although this effect has not been quantitated. These results indicate that the effects of GGF entiate and myelinate axons, which are likely to express neuregulins at their cell surface. One possibility is that are not isoform specific, consistent with previous reports that the epidermal growth factor domain is suffiduring CNS development, expression of neuregulin (Chen et al., 1994) or its receptors (Jin et al., 1993 ; Kokai cient to mediate the mitogenic effects of the neuregulins (Dong et al., 1995; Holmes et al., 1992; Morrissey et al., et al., 1987 ) (or both) are down-regulated. In addition, factors released by astroglia have been reported to over-1995). Potentially, methodologic differences between these studies may contribute to the different effects come the inhibition of differentiation of O-2A cells observed with PDGF or bFGF (Dutly and Schwab, 1991;  observed. First, Vartanian et al. also used supernatants from transfected COS cells as their source of ARIA, and Mayer et al., 1993) and could similarly modulate these effects of GGF in vivo.
therefore the concentration and purity of the material added to the oligodendrocyte progenitors is unknown. The effects of GGF on type-2 astrocytes are complex. Similar to its effects in the oligodendrocyte lineage, it Their studies were also done under serum-free conditions, which we have found significantly reduced the inhibits the differentiation of O-2A cells into type-2 astrocytes. However, it also promotes a dramatic change in mitogenic effect of GGF and accentuated its trophic effects. Finally, the cells used in our studies were exthe morphology of type-2 astrocytes that have already formed, resulting in the production of a few highly elonpanded with B104 conditioned media, which might enhance their responsiveness by up-regulating oligodengate processes (see Figure 1 and Figure 6 ). In addition, GGF has a modest, but significant, mitogenic effect on droglial neuregulin receptors akin to the increase in PDGF receptors observed with bFGF treatment (McKinthese cells. Some of these findings are similar to the effects of a neuregulin isoform, NDF, on type-1 astronon et al., 1990). cytes (Pinkas-Kramarski et al., 1994) . These investigators found that NDF had only a modest effect on A General Role for GGF in Regulating astrocyte proliferation, but promoted the formation of Myelinating Glial Cell Numbers more extensive processes. In addition, NDF promoted
The effects of GGF on the proliferation, survival, and astrocyte survival under serum-free conditions and inmaturation of oligodendrocyte progenitors are strikingly creased their maturation as evidenced by up-regulation similar to its effects on cells of the Schwann cell lineage. of GFAP expression, effects of GGF on type-2 astrocytes GGF has long been known to be a potent Schwann we have not analyzed.
cell mitogen and has recently been implicated in the We have further demonstrated that GGF inhibits the contact-dependent stimulation of Schwann cell proliferability of O-2A cells to commit to either the oligodendroation by neurons (Morrissey et al., 1995) . In other studies, cyte or astrocyte lineage. In the forebrain, O-2A cells GGF has been found to inhibit the expression of myelinarise primarily from the SVZ and, as noted, this is a specific proteins by Schwann cells (Cheng and Mudge, region of high level expression of GGF-related proteins. 1996) and their ability to myelinate axons (M. J. HanThese findings raise the possibility that high level exnocks, J. L. S., unpublished data). There also appears pression of GGF in this region may contribute to the to be a transition in the expression of neuregulin recephigh rate of proliferation and the multipotential nature tors in the Schwann cell lineage; progenitors, but not characteristic of cells in this region via an autocrine or mature Schwann cells, express erbB4 (Dong et al., 1995; paracrine mechanism. Although cells in the postnatal Levi et al., 1995) . This transition in receptor expression SVZ are multipotential with respect to the glial lineage, resembles that of the O-2A cells as they differentiate giving rise to either astrocytes or oligodendrocytes, they into oligodendrocytes (see Figure 8 ). These changes only rarely give rise to neurons (Levison and Goldman, in the repertoire of receptor heterodimers expressed 1993). Whether GGF commits these cells to the glial during the glial lineage, in turn, could be an important lineage as it does for cells of the neural crest origin determinant of the cellular response, regulating receptor (Shah et al., 1994) is not yet known.
affinity and determining which intracellular signaling pathways are activated (Carraway and Burden, 1995; Riese et al., 1995) . The Effects of GGF Are Not Isoform Specific These findings contrast with a previous study (Vartanian Of particular note, Schwann cells (Jessen et al., 1994 ) and oligodendrocytes (Barres et al., 1992 (Barres et al., ) are overproet al., 1994 , which reported that treatment of oligodendrocyte progenitors with ARIA, a related neuregulin isoduced during development and undergo apoptosis owing to limiting amounts of nerve-derived survival factors. form, results in increased numbers of O1ϩ cells from a progenitor population. In that study, treatment with ARIA In vitro, neurons promote the survival of oligodendrocyte progenitors by a mechanism involving neuronal memdid not increase the proliferation or survival of oligodendrocyte progenitors, and it was therefore suggested brane-associated factors (reviewed by Barres and Raff, 1994) . Recent studies have demonstrated that the neuthat ARIA promotes oligodendrocyte differentiation. As these findings are in sharp contrast with those reported regulins promote the survival of perinatal Schwann cells were diluted in 0.1% bovine serum albumin (BSA)/PBS as follows: (Trachtenberg and Thompson, 1996) and their precur-A2B5 monoclonal, 1:100; culture supernatants of the O4 monoclonal sors (Dong et al., 1995) . The trophic effects of GGF on and the O1 monoclonals were used at 1:10 and 1:1, respectively oligodendrocyte progenitors we have described here Center). The Sf9 conditioned media was used at a dilution of 1:100, detached by gentle flushing, replated onto poly-L-lysine-coated a concentration optimized by receptor phosphorylation studies. dishes, and allowed to adhere overnight. The O-2A cultures were Cortical neuron conditioned media was prepared as previously detreated with 5 mM leucine methylester (Sigma Chemical Company, scribed (Hardy and Reynolds, 1993b) . Neutralizing antibodies to St. Louis, MO) for 15 min at room temperature to kill any remaining bFGF (a gift of D. Rifkin, NYU Medical Center), PDGF (R & D) and microglia, and then washed three times with DMEM. O-2A cells were a rabbit polyclonal antibody raised against rhGGF2 (Cambridge Neugrown in N2 media containing 10 ng/ml biotin, 30 nM T3, and 0.5% roscience) were used. In experiments in which these antibodies were FBS (DM ϩ ) as described (McKinnon et al., 1990) and expanded by used to characterize mitogenic activities, purified growth factors or supplementing this media with either bFGF (5 ng/ml) and PDGF conditioned media were preincubated with the appropriate antibody (10 ng/ml) or, routinely, with 30% B104 conditioned media. (B104 for 30 min at 37ЊC prior to addition to the cells. In control studies, conditioned media was collected every 2 days from confluent culthe anti-PDGF antibody, alone or together with an anti-bFGF antitures of this neuroblastoma line that were maintained in DM ϩ .) Cells body, had no effect on the mitogenic activity of GGF whereas these expanded in this manner remained undifferentiated and highly prolifantibodies completely inhibited the mitogenic activity of bFGF and erative, as previously described (Bö gler et al., 1990; Bottenstein and PDGF, respectively (data not shown). Hunter, 1990) . After six passages, aliquots of 10 6 cells were prepared and frozen in liquid nitrogen. Individual aliquots were used for up to 3 months with no change in their bipolar morphology or their Survival Assays pattern of antigen expression. To generate cells of the oligodendroTo assess the effect of GGF on cell survival, cells growing in B104 cyte lineage, this media was removed and replaced with DM ϩ for conditioned media were changed to DM ϩ media for 3 days. They 1-3 days. To generate type-2 astrocytes, cells were switched to were then switched to either N2 media or DMEM, with or without DMEM supplemented with 20% FBS for 3 or more days.
GGF, for 12 or 24 hr and stained with the Live/Dead staining kit (Molecular Probes, Inc., Eugene, OR) for 15 min following the instructions of the manufacturer. This method relies on the differential Immunofluorescence Analysis Purity of the cultures was established by immunofluorescence analpermeability of live and dead cells to a pair of fluorescent nuclear stains (when viewed with epifluorescence microscopy, the nuclei of ysis using a series of antibodies directed against GFAP as a marker for astrocytes; OX42 monoclonal, a marker for microglia (Harlan live cells appear green whereas those of dead cells appear red). Because of fading of the green fluorescent dye, in later experiments Bioproducts for Science, Indianapolis, IN); anti-A2B5 monoclonal (Boehringer Mannheim, Indianapolis, IN), a marker for O-2A progeniwe used the Hoechst dye (Sigma) at 1 g/ml after fixation as a substitute with similar results and less fading. The number of red tors; O4 and O1, which recognize early and mature oligodendrocytes, respectively (Sommer and Schachner, 1980) . Cells used for and Hoechst dye-labeled nuclei in each field were then counted from the Ektachrome slides projected on a slide viewer; we counted immunofluorescence analysis were grown on poly-L-lysine-coated Lab-Tek eight chamber slides (Nunc). Slides were washed in phos-Ն1,000 cells per condition. In some experiments, we also used morphologic criteria, i.e., monitoring pyknotic cells under phase phate-buffered saline (PBS), fixed in 4% paraformaldehyde for 15 min, and processed for immunofluorescence. Primary antibodies microscopy, and the MTT assay (Sigma).
Analysis of GGF Receptors
Chen, M.S., Bermingham-McDonogh, O., Danehy, F., Jr., Nolan, C., Scherer, S.S., Lucas, J., Gwynne, D., and Marchionni, M.A. (1994) . To analyze the expression of GGF receptors, cells at different stages of the oligodendrocyte lineage were treated with rhGGF2 at 200 ng/ Expression of multiple neuregulin transcripts in postnatal rat brains. J. Comp. Neurol. 349, 389-400. ml in defined media for 2.5 min at 37ЊC. Cells were quickly rinsed twice with ice cold PBS and lysed in cold lysis buffer containing Chen, S.-J., and DeVries, G.H. (1989) . Mitogenic effect of axolemma-1% NP 40, 50 mM Tris HCl (pH 7.4), 150 mM NaCl, 10% glycerol, enriched fraction on cultured oligodendrocytes. J. Neurochem. 52, 5 mM EGTA, 1 mM Na orthovanadate, 10 mM Na molybdate, 8.8 325-327. g/L Na pyrophosphate, 4 g/L NaFl, 1 mM PMSF, 10 g/ml aprotinin, Cheng, L., and Mudge, A.W. (1996) . Cultured Schwann cells constiand 20 M leupeptin. Lysates were centrifuged at 12,000 ϫ g at tutively express the myelin protein P0. Neuron 16, 309-319. 4ЊC for 20 min, and supernatants were reserved for analysis. We
Collarini, E.J., Kuhn, R., Marshall, C.J., Monuki, E.S., Lemke, G., and fractionated 15 g of protein lysates by SDS-PAGE, electroblotted
Richardson, W.D. (1992) . Down-regulation of the POU transcription onto nitrocellulose, and probed with antibodies to either erbB2, factor is an early event in oligodendrocyte differentiation in vitro. erbB3, and erbB4 (Santa Cruz Biotechnology, Santa Cruz, CA) or Development 116, [193] [194] [195] [196] [197] [198] [199] [200] . with the anti-phosphotyrosine antibody RC 20 (Transduction Laboratories, Lexington, KY). Reacting protein bands were subsequently Corfas, G., Rosen, K.M., Aratake, H., Krauss, R., and Fischbach, visualized by chemiluminescence following the instructions of the G.D. (1995) . Differential expression of ARIA isoforms in the rat brain. manufacturer (Amersham, Arlington Heights, IL) . To analyze which Neuron 14, 103-115. receptor subunits were phosphorylated after GGF treatment, cells David, S., Miller, R.H., Patel, R., and Raff, M.C. (1984) . Effects of were lysed as above and aliquots of 150 g were incubated with neonatal transection on glial cell development in the rat optic nerve: the biotinylated RC 20 anti-phosphotyrosine antibody overnight at evidence that the oligodendrocyte-type-2 astrocyte cell lineage de-4ЊC. Immunoprecipitates were collected with streptavidin agarose pends on axons for its survival. J. Neurocytol. 13, 961-974. beads (Pierce Chemical Company, Rockford, IL) and released by Dong, Z., Brennan, A., Liu, N., Yarden, Y., Lefkowitz, G., Mirsky, R., boiling in SDS sample buffer. Samples were fractionated by SDSand Jessen, K.R. (1995) . Neu differentiation factor is a neuron-glia PAGE, electroblotted, and probed with the erbB-specific antibodies signal and regulates survival, proliferation, and maturation of rat as described above.
Schwann cell precursors. Neuron 15, 585-596.
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